硫酸氨基葡萄糖对ATDC5细胞分化与细胞外基质基因表达的影响

被引:0
作者
孙立胜
机构
[1] 南京大学
关键词
硫酸氨基葡萄糖; ATDC5; smad; 骨质疏松; GDF5基因; 单核苷酸多态性;
D O I
暂无
年度学位
2011
学位类型
硕士
导师
摘要
实验一、硫酸氨基葡萄对软骨细胞侏ATDC5细胞增殖分化与细胞外基质基因表达的影响 目的:从细胞水平观察硫酸氨基葡萄糖(glucosamine sulfate)对软骨细胞侏ATDC5细胞增殖分化及细胞外基质基因表达的影响,为硫酸氨基葡萄糖的临床应用提供实验依据。方法:体外培养软骨细胞侏ATDC5细胞,将软骨细胞株ATDC5分为硫酸氨基葡萄糖组(实验组)和空白对照组(对照组),阿利新蓝染色检测蛋白多糖(glycosaminoglycan, GAG)含量,碱性磷酸酶染色检测碱性磷酸酶活性,逆转录-聚合酶链反应(reverese transcript-polymerase chain rea ction, RT-PCR)检测Col2及Smad2, Runx2等。结果:硫酸氨基葡萄糖抑制了碱性磷酸酶的活性及smad2和runx2基因的表达,促进了蛋白多糖的合成与Col2基因的表达。结论:硫酸氨基葡萄糖不仅促进软骨基质的合成同时影响软骨细胞株ATDC5分化。 实验二、骨质疏松与GDF5基因多态性的相关性研究 目的:观察健康人群和骨质疏松(OP)患者中GDF5基因的基因型分布状况,并且进一步研究GDF5基因单核苷酸多态性与OP患者易感性之间的相关性。方法:选取177名(OP)患者,正常对照组108例,年龄50-80岁口腔拭子并抽提DNA,采用Taqman技术检测GDF5基因上的SNP位点(rs7605378)等位基因、基因型在实验组和对照组中的分布状况,行统计学分析,研究其与骨质疏松(OP)的相关性。结果:比较该位点病例组和对照组基因型构成,两者无显著差异性(P>0.05)。对性别比较也没有发现病例组与对照组的差异性。结论:在中国汉人群中,GDF5基因多态性位点(rs7605378)可能与OP的发病无相关性。
引用
收藏
页数:48
共 34 条
[1]
Risk of Wrist Fracture in Women Is Heritable and Is Influenced by Genes That Are Largely Independent of Those Influencing BMD.[J].TobyAndrew;LetoAntioniades;Katrina JScurrah;Alex JMacGregor;Tim DSpector.J Bone Miner Res.2009, 1
[2]
Collagen type 1 (COL1A1) Sp1 binding site polymorphism is associated with osteoporotic fractures but not with bone density in post-menopausal women from the Canary Islands: a preliminary study [J].
Navarro, Mary C. ;
Sosa, Manuel ;
del Pino-Montes, Javier ;
Torres, Armando ;
Salido, Eduardo ;
Saavedra, Pedro ;
Corral-Gudino, Luis ;
Montilla, Carlos A. .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (01) :4-9
[3]
Low‐Density Lipoprotein Receptor–Related Protein 5 ( LRP5 ) Gene Polymorphisms Are Associated With Bone Mass in Both Chinese and Whites.[J].Dong‐Hai Xiong;Shu‐Feng Lei;Fang Yang;Liang Wang;Yu‐Mei Peng;Wei Wang;Robert R Recker;Hong‐Wen Deng.J Bone Miner Res.2006, 3
[4]
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa [J].
Falchetti, A. ;
Sferrazza, C. ;
Cepollaro, C. ;
Gozzini, A. ;
Del Monte, F. ;
Masi, L. ;
Napoli, N. ;
Di Fede, G. ;
Cannone, V. ;
Cusumano, G. ;
Pandolfo, M. C. ;
Rini, G. B. ;
Tanini, A. ;
Brandi, M. L. .
CALCIFIED TISSUE INTERNATIONAL, 2007, 80 (01) :15-20
[5]
Recent advances in the genetic investigation of osteoarthritis [J].
Peach, CA ;
Carr, AJ ;
Loughlin, J .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (04) :186-191
[6]
Recombinant Human Bone Morphogenetic Proteins in the Treatment of Fractures.[J].Michael S.H. Kain;Thomas A. Einhorn.Foot and Ankle Clinics of North America.2005, 4
[7]
Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits [J].
Schadt, EE .
CURRENT OPINION IN BIOTECHNOLOGY, 2005, 16 (06) :647-654
[8]
Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture:: The Rotterdam study [J].
Fang, Y ;
van Meurs, JBJ ;
d'Alesio, A ;
Jhamai, M ;
Zhao, HY ;
Rivadeneira, F ;
Hofman, A ;
van Leeuwen, JPT ;
Jehan, F ;
Pols, HAP ;
Uitterlinden, AG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (05) :807-823
[9]
High-resolution whole-genome association study of Parkinson disease [J].
Maraganore, DM ;
de Andrade, M ;
Lesnick, TG ;
Strain, KJ ;
Farrer, MJ ;
Rocca, WA ;
Pant, PVK ;
Frazer, KA ;
Cox, DR ;
Ballinger, DG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (05) :685-693
[10]
Recent developments in genomewide association scans: A workshop summary and review [J].
Thomas, DC ;
Haile, RW ;
Duggan, D .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (03) :337-345